Clinical Assessment and Utility of Biomarkers in Asthma-Chronic Obstructive Pulmonary Disease Overlap.

doi:10.1016/j.iac.2022.04.004

Back to search

Article

Clinical Assessment and Utility of Biomarkers in Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Immunology and allergy clinics of North America - 1 Aug 2022

Huang Kewu, Chung Kian Fan

Abstract excerpt

Although asthma and chronic obstructive pulmonary disease (COPD) are considered as 2 distinct airway disorders, asthma-COPD overlap (ACO) includes those with features of both asthma and COPD. ACO is distinguished by having more frequent exacerbations and being associated with higher medical costs...

Topics

Asthma
Biomarkers
Humans
Phenotype
Pulmonary Disease, Chronic Obstructive

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.